Skip to main content
SpringerLink
Log in

Adiponectin expression and metabolic markers in obesity and Type 2 diabetes

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Adiponectin has emerged over the last decade as a key adipokine linking obesity, insulin resistance, and Type 2 diabetes. However, the molecular mechanisms controlling adiponectin expression in adipose tissue are not fully elucidated. Furthermore, increasing evidence indicates that peroxisome proliferator-activated receptor-γ (PPAR-γ) plays an important, and beneficial, role in modulating adiponectin expression. Aim: The aim of the present study was to assess the separate role of obesity and Type 2 diabetes in the relationship between endogenous PPAR-γ signaling and adiponectin expression in subcutaneous adipose tissue. Subjects and methods: Enzyme-linked immuno sor bent assay and real time quantitative PCR analysis were carried out in overweight, obese, and/or diabetic Tunisian patients who underwent an abdominal surgery. Results: These results collectively indicate that circulating levels of adiponectin were decreased in all over-weight, obese, and/or diabetic (p<0.001). However, the subcutaneous mRNA expression of adiponectin was reduced only in diabetics (p<0.01) but presents some discrepancies in obese individuals. Moreover, mRNA levels of adiponectin were positively correlated with levels of mRNA encoding PPARγ and its heterodimeric partner retinoid X receptor-α (RXR-α), in both obese and diabetic patients. Conclusion: Our study on Tunisian patients shows impaired regulation of circulating and mRNA adiponectin levels dependent of metabolic disorders in obesity and Type 2 diabetes. The data suggest that subcutaneous adipose tissue may play an important role in modulating adiponectin expression in diabetes and obesity. Moreover, adiponectin mRNA could be potentially regulated by endogenous PPARγ/RXRα-dependent pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Attie AD, Scherer PE. Adipocyte metabolism and obesity. J Lipid Res 2008, 50 (Suppl): S395–9.

    Article  PubMed  CAS  Google Scholar 

  2. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006, 64: 355–65.

    CAS  Google Scholar 

  3. Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulinresistant adipose tissue. Circ Res 2005, 96: 1042–52.

    Article  PubMed  CAS  Google Scholar 

  4. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004, 30: 13–9.

    Article  PubMed  CAS  Google Scholar 

  5. Garaulet M, Hernández-Morante JJ, de Heredia FP, Tébar FJ. Adiponectin, the controversial hormone. Public Health Nutr 2007, 10: 1145–50.

    Article  PubMed  Google Scholar 

  6. Matsuzawa Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 2005, 6: 7–14.

    Article  PubMed  CAS  Google Scholar 

  7. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270: 26746–9.

    Article  PubMed  CAS  Google Scholar 

  8. Gil-Campos M, Cañete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004, 23: 963–74.

    Article  PubMed  CAS  Google Scholar 

  9. Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52: 1655–63.

    Article  PubMed  CAS  Google Scholar 

  10. Geloneze B, Pereira JA, Pareja JC, et al. Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass. Arq Bras Endocrinol Metabol 2009, 53: 293–300.

    Article  PubMed  Google Scholar 

  11. Nishida M, Funahashi T, Shimomura I. Pathophysiological significance of adiponectin. Med Mol Morphol 2007, 40: 55–67.

    Article  PubMed  CAS  Google Scholar 

  12. Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) 2006, 110: 267–78.

    Article  CAS  Google Scholar 

  13. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006, 2: 367–73.

    Article  PubMed  Google Scholar 

  14. Drolet R, Bélanger C, Fortier M, et al. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity (Silver Spring) 2009, 17: 424–30.

    Article  CAS  Google Scholar 

  15. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23: 57–63.

    Article  PubMed  CAS  Google Scholar 

  16. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20: 1595–9.

    Article  PubMed  CAS  Google Scholar 

  17. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86: 1930–5.

    Article  PubMed  CAS  Google Scholar 

  18. Owecki M, Sowinski J. [Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance]. Pol Merkur Lekarski 2006, 20: 355–7.

    PubMed  CAS  Google Scholar 

  19. Gavrila A, Chan JL, Yiannakouris N, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 2003, 88: 4823–31.

    Article  PubMed  CAS  Google Scholar 

  20. Shand BI, Scott RS, Elder PA, George PM. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 2003, 5: 349–53.

    Article  PubMed  CAS  Google Scholar 

  21. Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Int J Obes (Lond) 2007, 31: 213–20.

    Article  CAS  Google Scholar 

  22. Tabak AG, Brunner EJ, Miller MA, et al. Low serum adiponectin predicts 10-year risk of type 2 diabetes and hba1c independently of obesity, lipids, and inflammation: Whitehall II study. Horm Metab Res 2009, 41: 626–9.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  23. Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care 2003, 26: 2015–20.

    Article  PubMed  CAS  Google Scholar 

  24. Snijder MB, Heine RJ, Seidell JC, et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Diabetes Care 2006, 29: 2498–503.

    Article  PubMed  CAS  Google Scholar 

  25. Hivert MF, Sullivan LM, Fox CS, et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008, 93: 3165–72.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  26. Lihn AS, Østergard T, Nyholm B, Pedersen SB, Richelsen B, Schmitz O. Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 2003, 284: E443-8.

    Google Scholar 

  27. Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003, 285: E527–33.

    PubMed  CAS  Google Scholar 

  28. Lihn AS, Richelsen B, Pedersen SB, et al. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab 2003, 285: E1072–80.

    PubMed  CAS  Google Scholar 

  29. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004, 219: 9–15.

    Article  PubMed  CAS  Google Scholar 

  30. Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004, 68: 975–81.

    Article  PubMed  CAS  Google Scholar 

  31. Ohashi N, Ito C, Fujikawa R, Yamamoto H, Kihara Y, Kohno N. The impact of visceral adipose tissue and high-molecular weight adiponectin on cardio-ankle vascular index in asymptomatic Japanese subjects. Metabolism 2009, 58: 1023–9.

    Article  PubMed  CAS  Google Scholar 

  32. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002, 13: 84–9.

    Article  PubMed  CAS  Google Scholar 

  33. Savu MK, Phillips SA, Oh DK, et al. Response of adiponectin and its receptors to changes in metabolic state after gastric bypass surgery: dissociation between adipose tissue expression and circulating levels. Surg Obes Relat Dis 2009, 5: 172–80.

    Article  PubMed  Google Scholar 

  34. Yang WS, Chen MH, Lee WJ, et al. Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women. Int J Obes Relat Metab Disord 2003, 27: 896–900.

    Article  PubMed  CAS  Google Scholar 

  35. Ribot J, Rodriguez AM, Rodriguez E, Palou A. Adiponectin and resistin response in the onset of obesity in male and female rats. Obesity (Silver Spring) 2008, 16: 723–30.

    Article  CAS  Google Scholar 

  36. Liu YM, Lacorte JM, Viguerie N, et al. Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding. J Clin Endocrinol Metab 2003, 88: 5881–6.

    Article  PubMed  CAS  Google Scholar 

  37. Horenburg S, Fischer-Posovszky P, Debatin KM, Wabitsch M. Influence of sex hormones on adiponectin expression in human adipocytes. Horm Metab Res 2008, 40: 779–86.

    Article  PubMed  CAS  Google Scholar 

  38. Plaisance EP, Grandjean PW, Judd RL, Jones KW, Taylor JK. The influence of sex, body composition, and nonesterified fatty acids on serum adipokine concentrations. Metabolism 2009, 58: 1557–63.

    Article  PubMed  CAS  Google Scholar 

  39. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003, 52: 1779–85.

    Article  PubMed  CAS  Google Scholar 

  40. Xie L, O’Reilly CP, Chapes SK, Mora S. Adiponectin and leptin are secreted through distinct trafficking pathways in adipocytes. Biochim Biophys Acta 2008, 1782: 99–108.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  41. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444: 881–7.

    Article  PubMed  CAS  Google Scholar 

  42. Barth N, Langmann T, Schölmerich J, Schmitz G, Schäffler A. Identification of regulatory elements in the human adipose most abundant gene transcript-1 (apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways. Diabetologia 2002, 45: 1425–33.

    PubMed  CAS  Google Scholar 

  43. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002, 8: 731–7.

    Article  PubMed  CAS  Google Scholar 

  44. Phillips SA, Ciaraldi TP, Oh DK, Savu MK, Henry RR. Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue. Am J Physiol Endocrinol Metab 2008, 295: E842–50.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Genetics, Immunology and Human Pathology, Biology Department, Faculté Des Sciences de Tunis, CAMPUS, El Manar University, Tunis, Tunisia

    S. Kouidhi PhD, R. Marrakchi, H. Abid, H. Guissouma & A. Benammar Elgaaied

  2. Visceral Surgical Service, Charles Nicolles Hospital, Tunis, Tunisia

    S. Jarboui

  3. CNRS UMR 7221 Laboratory of Endocrine Regulations Evolution, Department of Regulations, Development and Molecular Diversity, Muséum National de l’Histoire Naturelle, Paris, France

    M. S. Clerget Froidevaux, I. Seugnet & B. Demeneix

  4. Laboratory of Radioimmunology, Pasteur Institute, Tunis, Tunisia

    F. Bchir & M. Brahem

Authors
  1. S. Kouidhi PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Jarboui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Marrakchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. S. Clerget Froidevaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Seugnet
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Abid
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Bchir
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Brahem
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B. Demeneix
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H. Guissouma
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A. Benammar Elgaaied
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Kouidhi PhD.

Additional information

Co-second authors

Co-last authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kouidhi, S., Jarboui, S., Marrakchi, R. et al. Adiponectin expression and metabolic markers in obesity and Type 2 diabetes. J Endocrinol Invest 34, e16–e23 (2011). https://doi.org/10.1007/BF03347056

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347056

Key-words

Search

Navigation